A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation Article

Pathak, Rakesh K, Basu, Uttara, Ahmad, Anis et al. (2018). A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation . BIOMATERIALS, 187 117-129. 10.1016/j.biomaterials.2018.08.062

Open Access

cited authors

  • Pathak, Rakesh K; Basu, Uttara; Ahmad, Anis; Sarkar, Shrita; Kumar, Anil; Surnar, Bapurao; Ansari, Saba; Wilczek, Katarzyna; Ivan, Michael E; Marples, Brian; Kolishetti, Nagesh; Dhar, Shanta

sustainable development goals

authors

publication date

  • December 1, 2018

published in

keywords

  • Aspirin prodrug
  • CELLS
  • CISPLATIN-INDUCED APOPTOSIS
  • Cancer stem cells
  • Cisplatin prodrug
  • DOSE HYPER-RADIOSENSITIVITY
  • Engineering
  • Engineering, Biomedical
  • H2AX PHOSPHORYLATION
  • IONIZING-RADIATION
  • Inflammation
  • MEMBRANE ANTIGEN
  • MITOCHONDRIAL-DNA
  • Materials Science
  • Materials Science, Biomaterials
  • Mitochondria
  • PROSTATE-CANCER
  • REPAIR
  • Radiation therapy
  • Science & Technology
  • TARGETED DELIVERY
  • Targeted nanoparticles
  • Technology

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCI LTD

start page

  • 117

end page

  • 129

volume

  • 187